Synthesis and enantioselective mutagenicity of azidoalanine in Salmonella typhimurium

Chem Biol Interact. 1986 Nov;60(2):183-90. doi: 10.1016/0009-2797(86)90026-8.

Abstract

Azide mutagenicity involves the requisite formation of the putative novel aminoacid metabolite, beta-azidoalanine. The role of this metabolite, however, is unclear. In order to confirm the identity of this metabolite and provide additional information on possible stereochemical requirements for mutagenicity, authentic racemic and L-azidoalanine were synthesized by an unambiguous route and tested for mutagenicity in Salmonella typhimurium TA100, TA1535, hisG46 and Escherichia coli WP2-. A marked antipodal potency ratio was observed in strains TA100 and TA1535 when racemic and L-azidoalanine were compared. The mutagenic activity resided primarily in the L-isomer. The molar potency of L-azidoalanine in TA100 and TA1535 was nearly identical to that of azide. The lack of mutagenic response for racemic or L-azidoalanine in hisG46 and E. coli WP2- was like that reported for azide and is consistent with similar modes of action for these agents.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Alanine / analogs & derivatives*
  • Alanine / toxicity
  • Azides / toxicity*
  • Escherichia coli / drug effects
  • Mutagenicity Tests
  • Salmonella typhimurium / drug effects*
  • Stereoisomerism

Substances

  • Azides
  • azidoalanine
  • Alanine